Literature DB >> 7538819

Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells.

D K Blanchard1, S Wei, C Duan, F Pericle, J I Diaz, J Y Djeu.   

Abstract

The lysis of antigen presenting cells (APCs) by cytotoxic T lymphocytes (CTLs) may be one mechanism whereby an immune response is downregulated by Staphylococcus superantigens. Disappearance of monocytes/macrophages from staphylococcal enterotoxin A (SEA)-activated peripheral blood mononuclear cell (PBMC) cultures, but not from control PBMC cultures was seen by flow cytometry. Recently, adenosine triphosphate (ATP) has been described as an effector molecule in CTL-mediated lysis of some murine tumor target cells. We have also shown that ATP caused the lysis of human macrophages, and that treatment of cells with interferon gamma (IFN gamma) rendered macrophages significantly more sensitive to ATP than untreated cells. To show that this purine nucleotide may play a role in modulating the immune system, we generated human CTLs that were stimulated with SEA, and used them as effector cells against SEA-pulsed autologous macrophages. CTLs were found to specifically lyse SEA-pulsed macrophages, while control, unpulsed, macrophages were unaffected. The addition of hexokinase, an enzyme that hydrolyzes ATP, significantly abrogated the killing of SEA-pulsed cells during the assay. In examining the mechanism of cytotoxicity, electron microscopy showed that macrophages incubated with both ATP and CTLs underwent necrosis, rather than apoptosis. From these results, it is suggested that ATP is released from CTLs during antigen presentation, and that IFN gamma-activated macrophages, which are inherently more sensitive to this mediator, are readily lysed and therefore removed from circulation, thus downregulating an immune response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538819

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65.

Authors:  C L Silva; M F Silva; R C Pietro; D B Lowrie
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells.

Authors:  R X Faria; C M Cascabulho; R A M Reis; Luiz Anastácio Alves
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-28       Impact factor: 3.000

Review 3.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 4.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 5.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

6.  Studies on the cytotoxic, biochemical and anti-carcinogenic potentials of ninhydrin on Ehrlich ascites carcinoma cell-bearing Swiss albino mice.

Authors:  S Qureshi; O A Al-Shabanah; A M Al-Bekairi; M M Al-Harbi; N M Al-Gharably; M Raza
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

8.  Autocrine regulation of T-cell activation by ATP release and P2X7 receptors.

Authors:  Linda Yip; Tobias Woehrle; Ross Corriden; Mark Hirsh; Yu Chen; Yoshiaki Inoue; Vhe Ferrari; Paul A Insel; Wolfgang G Junger
Journal:  FASEB J       Date:  2009-02-11       Impact factor: 5.191

9.  Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment.

Authors:  A Kuhnke; G-R Burmester; S Krauss; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

10.  Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages.

Authors:  Bala Krishna Kolli; Jan Kostal; Olga Zaborina; Ananda M Chakrabarty; Kwang-Poo Chang
Journal:  Mol Biochem Parasitol       Date:  2007-12-25       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.